Studies on the reversal of the selective antitumour effect of the aziridinyl derivative CB 1954 by 4-amino-5-imidazolecarboxamide.
D000241:Adenosine / Q000378:metabolism; D000577:Amides / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000818:Animals; D001389:Azirines / Q000037:antagonists & inhibitors*; D001565:Benzoates / Q000037:antagonists & inhibitors; D002279:Carcinoma 256, Walker / Q000378:metabolism*; D002855:Chromatography, Thin Layer; D003545:Cysteine / Q000378:metabolism; D006151:Guanosine / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology*; D007288:Inosine / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D008297:Male; D009574:Nitro Compounds / Q000037:antagonists & inhibitors; D011687:Purines / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000577:Amides; D000588:Amines; D001389:Azirines; D001565:Benzoates; D007093:Imidazoles; D009574:Nitro Compounds; D011687:Purines; D011743:Pyrimidines; D062367:ortho-Aminobenzoates; D014316:Tritium; D006151:Guanosine; D007288:Inosine; D007930:Leucine; D000241:Adenosine; D003545:Cysteine; D013936:Thymidine; D014529:Uridine